CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
70.81
1.33%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.14
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Henry Schein Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 69.88
Open* 69.96
1-Year Change* -15.38%
Day's Range* 69.96 - 70.85
52 wk Range 60.01-89.72
Average Volume (10 days) 1.10M
Average Volume (3 months) 25.09M
Market Cap 9.65B
P/E Ratio 22.10
Shares Outstanding 129.94M
Revenue 12.69B
EPS 3.36
Dividend (Yield %) N/A
Beta 0.87
Next Earnings Date Feb 14, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 70.81 1.13 1.62% 69.68 70.92 69.41
Apr 18, 2024 69.88 -0.03 -0.04% 69.91 70.17 69.34
Apr 17, 2024 70.14 -0.79 -1.11% 70.93 71.78 70.06
Apr 16, 2024 71.17 1.19 1.70% 69.98 71.34 69.98
Apr 15, 2024 70.67 -0.21 -0.30% 70.88 71.81 70.53
Apr 12, 2024 70.95 0.13 0.18% 70.82 71.38 70.08
Apr 11, 2024 71.75 0.08 0.11% 71.67 71.93 71.02
Apr 10, 2024 71.79 -0.17 -0.24% 71.96 72.30 71.55
Apr 9, 2024 73.12 1.13 1.57% 71.99 73.14 71.72
Apr 8, 2024 72.39 0.16 0.22% 72.23 73.21 71.95
Apr 5, 2024 72.46 0.61 0.85% 71.85 72.75 71.85
Apr 4, 2024 72.81 -0.40 -0.55% 73.21 73.85 72.63
Apr 3, 2024 73.36 0.75 1.03% 72.61 73.60 72.44
Apr 2, 2024 72.99 -0.76 -1.03% 73.75 73.97 72.94
Apr 1, 2024 74.16 -0.60 -0.80% 74.76 74.93 73.62
Mar 28, 2024 75.44 0.57 0.76% 74.87 76.08 74.04
Mar 27, 2024 75.12 2.61 3.60% 72.51 75.13 72.51
Mar 26, 2024 72.82 0.51 0.71% 72.31 73.23 72.31
Mar 25, 2024 72.82 0.32 0.44% 72.50 73.37 72.50
Mar 22, 2024 73.02 -0.68 -0.92% 73.70 73.82 72.35

Henry Schein, Inc. Events

Time (UTC) Country Event
Tuesday, May 7, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Henry Schein Inc Earnings Release
Q1 2024 Henry Schein Inc Earnings Release

Forecast

-

Previous

-

Time (UTC)

14:00

Country

US

Event

Q1 2024 Henry Schein Inc Earnings Call
Q1 2024 Henry Schein Inc Earnings Call

Forecast

-

Previous

-
Tuesday, May 21, 2024

Time (UTC)

14:00

Country

US

Event

Henry Schein Inc Annual Shareholders Meeting
Henry Schein Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, May 22, 2024

Time (UTC)

14:00

Country

US

Event

Henry Schein Inc Annual Shareholders Meeting
Henry Schein Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, August 5, 2024

Time (UTC)

12:30

Country

US

Event

Q2 2024 Henry Schein Inc Earnings Release
Q2 2024 Henry Schein Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 12647 12401 10119.1 9985.8 9417.6
Revenue 12647 12401 10119.1 9985.8 9417.6
Cost of Revenue, Total 8816 8728.77 7304.91 6894.92 6506.86
Gross Profit 3831 3672.25 2814.23 3090.89 2910.75
Total Operating Expense 11900 11549.4 9583.84 9267.54 8816.98
Selling/General/Admin. Expenses, Total 2771 2812.66 2246.83 2357.92 2217.27
Unusual Expense (Income) 131 7.939 32.093 14.705 92.855
Operating Income 747 851.656 535.303 718.261 600.619
Interest Income (Expense), Net Non-Operating -27 -21.149 -31.535 -35.035 -60.525
Other, Net 1 0.041 -3.873 -2.919 -3.258
Net Income Before Taxes 721 830.548 499.895 680.307 536.836
Net Income After Taxes 551 633.199 404.521 520.792 417.728
Minority Interest -28 -29.294 -15.629 -24.77 -19.724
Equity In Affiliates 15 27.327 13.916 204.669 21.037
Net Income Before Extra. Items 538 631.232 402.808 700.691 419.041
Total Extraordinary Items 0 0 0.986 -5.957 116.84
Net Income 538 631.232 403.794 694.734 535.881
Income Available to Common Excl. Extra. Items 538 631.232 402.808 700.691 419.041
Income Available to Common Incl. Extra. Items 538 631.232 403.794 694.734 535.881
Diluted Net Income 538 631.232 403.794 694.734 535.881
Diluted Weighted Average Shares 137.756 141.773 143.404 149.257 153.707
Diluted EPS Excluding Extraordinary Items 3.90547 4.45241 2.8089 4.69453 2.72623
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS 4.85411 4.53436 3.13784 4.76995 3.1963
Dilution Adjustment
Depreciation / Amortization 182
Jul 2023 Apr 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 3100 3060 3371 3067 3030
Revenue 3100 3060 3371 3067 3030
Cost of Revenue, Total 2125 2094 2372 2153 2085
Gross Profit 975 966 999 914 945
Total Operating Expense 2899 2885 3299 2856 2810
Selling/General/Admin. Expenses, Total 707 717 761 648 680
Unusual Expense (Income) 18 30 121 10 0
Operating Income 201 175 72 211 220
Interest Income (Expense), Net Non-Operating -16 -11 -9 -7 -6
Other, Net 1 -1 0 1 0
Net Income Before Taxes 186 163 63 205 214
Net Income After Taxes 145 124 48 159 162
Minority Interest -8 -7 -4 -12 -7
Equity In Affiliates 3 4 3 3 5
Net Income Before Extra. Items 140 121 47 150 160
Total Extraordinary Items 0
Net Income 140 121 47 150 160
Income Available to Common Excl. Extra. Items 140 121 47 150 160
Income Available to Common Incl. Extra. Items 140 121 47 150 160
Diluted Net Income 140 121 47 150 160
Diluted Weighted Average Shares 131.873 133.04 135.558 137.084 138.869
Diluted EPS Excluding Extraordinary Items 1.06163 0.9095 0.34672 1.09422 1.15216
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Diluted Normalized EPS 1.16803 1.08104 1.3022 1.1508 1.15216
Depreciation / Amortization 49 44 45 45 45
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 3988 3844.03 3791.42 3226.5 4175.22
Cash and Short Term Investments 117 117.965 421.185 106.097 56.885
Cash & Equivalents 117 117.965 421.185 106.097 56.885
Total Receivables, Net 1442 1451.83 1424.79 1246.25 1168.78
Accounts Receivable - Trade, Net 1442 1451.83 1424.79 1246.25 1168.78
Total Inventory 1963 1861.14 1512.5 1428.8 1415.51
Prepaid Expenses 466 413.103 432.944 445.36 451.033
Total Assets 8607 8481.09 7772.53 7151.1 8500.53
Property/Plant/Equipment, Total - Net 667 691.406 630.851 561.307 314.221
Property/Plant/Equipment, Total - Gross 1240 1241.69 1157.03 1030.25 0
Accumulated Depreciation, Total -573 -550.286 -526.178 -468.946
Goodwill, Net 2893 2854.15 2504.39 2462.5 2081.03
Intangibles, Net 587 667.626 479.429 572.882 376.031
Long Term Investments 161 168.118 169.382 207.638 420.367
Note Receivable - Long Term 28 35.748 34.76 43.544
Other Long Term Assets, Total 283 220.008 162.303 76.733 1133.66
Total Current Liabilities 2224 2306.51 2283.1 2038.37 3218.83
Accounts Payable 1004 1053.93 1005.66 880.266 785.756
Accrued Expenses 893 965.291 884.074 859.108 741.113
Notes Payable/Short Term Debt 103 50.53 73.366 23.975 951.458
Current Port. of LT Debt/Capital Leases 6 10.64 109.836 109.849 8.28
Other Current Liabilities, Total 218 226.119 210.171 165.171 732.22
Total Liabilities 5161 5055.96 4424.36 4153.06 5539.19
Total Long Term Debt 1040 811.346 515.773 622.908 980.344
Long Term Debt 1034 807.386 512.232 619.25 980.344
Deferred Income Tax 36 42.283 30.065 64.989 27.218
Minority Interest 1225 1251.38 963.912 919.351 800.18
Other Liabilities, Total 636 644.444 631.508 507.44 512.626
Total Equity 3446 3425.13 3348.17 2998.04 2961.33
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 1 1.371 1.425 1.434 1.514
Additional Paid-In Capital 0 0 0 47.768 0
Retained Earnings (Accumulated Deficit) 3678 3595.23 3454.83 3116.22 3208.59
Unrealized Gain (Loss) -0.008 0.001 0.006 -0.006
Other Equity, Total -233 -171.47 -108.085 -167.379 -248.765
Total Liabilities & Shareholders’ Equity 8607 8481.09 7772.53 7151.1 8500.53
Total Common Shares Outstanding 131.793 137.146 142.463 143.353 151.402
Other Current Assets, Total 0 1083.01
Capital Lease Obligations 6 3.96 3.541 3.658
Sep 2023 Jul 2023 Apr 2023 Dec 2022 Sep 2022
Total Current Assets 3911 3952 3988 3957
Cash and Short Term Investments 137 126 117 123
Cash & Equivalents 137 126 117 123
Total Receivables, Net 1468 1470 1442 1507
Accounts Receivable - Trade, Net 1468 1470 1442 1507
Total Inventory 1843 1918 1963 1818
Prepaid Expenses 463 438 466 509
Total Assets 9146 8572 8607 8534
Property/Plant/Equipment, Total - Net 729 676 667 673
Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Goodwill, Net 3335 2917 2893 2870
Intangibles, Net 678 548 587 635
Long Term Investments 493 479 472 399
Total Current Liabilities 2276 2172 2224 2146
Accounts Payable 817 855 1004 957
Accrued Expenses 939 870 979 951
Notes Payable/Short Term Debt 325 236 103 107
Current Port. of LT Debt/Capital Leases 66 55 6 4
Other Current Liabilities, Total 129 156 132 127
Total Liabilities 5586 5100 5161 4923
Total Long Term Debt 1133 1021 1040 934
Long Term Debt 1117 1012 1034 927
Capital Lease Obligations 16 9 6 7
Deferred Income Tax 50 40 36 37
Minority Interest 1446 1225 1225 1197
Other Liabilities, Total 681 642 636 609
Total Equity 3560 3472 3446 3611
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 1 1 1 1
Additional Paid-In Capital 0 0 0 0
Retained Earnings (Accumulated Deficit) 3769 3684 3678 3922
Unrealized Gain (Loss)
Other Equity, Total -210 -213 -233 -312
Total Liabilities & Shareholders’ Equity 9146 8572 8607 8534
Total Common Shares Outstanding 130.577 131.197 131.793 135.259
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 566 660.526 419.423 719.138 562.126
Cash From Operating Activities 602 709.58 598.91 675.171 681.188
Cash From Operating Activities 212 209.528 185.538 184.942 143.63
Deferred Taxes -73 -10.985 -52.977 -4.057 -36.007
Non-Cash Items 163 29.95 34.296 -270.425 154.102
Cash Taxes Paid 265 241.887 206.796 177.277 236.479
Cash Interest Paid 47 29.455 43.123 54.685 69.371
Changes in Working Capital -266 -179.439 12.63 45.573 -142.663
Cash From Investing Activities -276 -677.217 -115.019 -424.373 -192.954
Capital Expenditures -96 -79.015 -48.829 -76.219 -71.283
Other Investing Cash Flow Items, Total -180 -598.202 -66.19 -348.154 -121.671
Cash From Financing Activities -315 -332.957 -187.185 -215.98 -603.776
Financing Cash Flow Items -91 -96.068 -48.683 1136.01 -707.858
Issuance (Retirement) of Stock, Net -483 -401.211 -73.789 -163.876 -196.924
Issuance (Retirement) of Debt, Net 259 164.322 -64.713 -1188.11 301.006
Foreign Exchange Effects -12 -2.626 18.382 14.394 14.425
Net Change in Cash -1 -303.22 315.088 49.212 -101.117
Apr 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 128 566 515 353 186
Cash From Operating Activities 27 602 348 250 93
Cash From Operating Activities 52 212 160 108 55
Deferred Taxes 2 -73 -20 -15 -3
Non-Cash Items 14 163 10 4 6
Cash Taxes Paid 21 265 235 165 21
Cash Interest Paid 13 47 29 17 8
Changes in Working Capital -169 -266 -317 -200 -151
Cash From Investing Activities -39 -276 -211 -59 -27
Capital Expenditures -31 -96 -67 -43 -19
Other Investing Cash Flow Items, Total -8 -180 -144 -16 -8
Cash From Financing Activities 21 -315 -121 -195 -62
Financing Cash Flow Items -42 -91 -81 -60 -41
Issuance (Retirement) of Stock, Net -99 -483 -198 -108 2
Issuance (Retirement) of Debt, Net 162 259 158 -27 -23
Foreign Exchange Effects 0 -12 -11 -6 4
Net Change in Cash 9 -1 5 -10 8

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Henry Schein Company profile

About Henry Schein, Inc.

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company’s segments include Health care distribution and Technology and value-added services. The Health care distribution segment distributes consumable products, laboratory products, equipment repair services, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions, medical practitioners and ambulatory surgery centers. The Technology and value-added services segments provides software, technology and other value-added services to health care practitioners. It also offers practice management software systems for dental and medical practitioners. The Company's value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services.

Financial summary

BRIEF: For the fiscal year ended 25 December 2021, Henry Schein, Inc. revenues increased 23% to $12.4B. Net income before extraordinary items increased 57% to $631.2M. Revenues reflect Dental segment increase of 28% to $7.54B, Medical segment increase of 17% to $4.22B, Technology and value-added services segment increase of 25% to $640.9M, United States segment increase of 23% to $8.72B, International segment increase of 21% to $3.68B.

Equity composition

Common Stock $.01 Par, 04/11, 240M auth., 92,251,522 o/s. Insiders & Strategic holders own 1.42%. IPO 11/95, 6,165,000 shs. @ $16 by William Blair. *FY'00 Q's are reclassified. 3/05, 2-for-1 stock split.

Industry: Medical Equipment Wholesale

135 Duryea Rd
MELVILLE
NEW YORK 11747
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

US100

17,037.80 Price
-1.980% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

64,751.80 Price
+1.000% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.54 Price
+5.040% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,157.46 Price
+2.490% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading